Ningbo Sinyuan ZM Technology Co Ltd
SZSE:301398
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Ningbo Sinyuan ZM Technology Co Ltd
SZSE:301398
|
CN |
|
Jubilant Pharmova Ltd
NSE:JUBLPHARMA
|
IN |
|
Sendas Distribuidora SA
BOVESPA:ASAI3
|
BR |
Income Statement
Earnings Waterfall
Ningbo Sinyuan ZM Technology Co Ltd
Income Statement
Ningbo Sinyuan ZM Technology Co Ltd
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
262
N/A
|
271
+3%
|
351
+30%
|
315
-10%
|
324
+3%
|
352
+9%
|
354
+1%
|
364
+3%
|
387
+6%
|
409
+6%
|
415
+1%
|
409
-1%
|
413
+1%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(170)
|
(171)
|
(224)
|
(202)
|
(206)
|
(230)
|
(231)
|
(244)
|
(261)
|
(268)
|
(272)
|
(271)
|
(278)
|
|
| Gross Profit |
92
N/A
|
100
+8%
|
127
+27%
|
113
-11%
|
118
+4%
|
123
+4%
|
123
+0%
|
121
-1%
|
125
+3%
|
140
+12%
|
143
+2%
|
138
-4%
|
135
-2%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(38)
|
(42)
|
(52)
|
(49)
|
(52)
|
(55)
|
(55)
|
(53)
|
(55)
|
(61)
|
(64)
|
(65)
|
(69)
|
|
| Selling, General & Administrative |
(26)
|
(27)
|
(34)
|
(33)
|
(34)
|
(35)
|
(34)
|
(34)
|
(35)
|
(40)
|
(40)
|
(38)
|
(41)
|
|
| Research & Development |
(12)
|
(13)
|
(18)
|
(16)
|
(18)
|
(18)
|
(20)
|
(21)
|
(22)
|
(18)
|
(23)
|
(23)
|
(24)
|
|
| Depreciation & Amortization |
0
|
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(0)
|
4
|
1
|
(0)
|
(1)
|
3
|
(1)
|
2
|
2
|
6
|
(1)
|
(3)
|
(4)
|
|
| Operating Income |
55
N/A
|
58
+6%
|
76
+30%
|
64
-15%
|
66
+2%
|
67
+3%
|
68
+0%
|
68
+1%
|
71
+3%
|
80
+13%
|
79
-2%
|
73
-7%
|
66
-9%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
2
|
5
|
7
|
11
|
14
|
17
|
18
|
14
|
12
|
12
|
12
|
12
|
11
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
6
|
(0)
|
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
57
N/A
|
63
+11%
|
83
+31%
|
75
-9%
|
79
+6%
|
91
+14%
|
92
+1%
|
88
-4%
|
88
0%
|
91
+4%
|
90
-1%
|
84
-6%
|
78
-8%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
(7)
|
(7)
|
(9)
|
(9)
|
(9)
|
(11)
|
(11)
|
(10)
|
(10)
|
(11)
|
(10)
|
(9)
|
(8)
|
|
| Income from Continuing Operations |
50
|
56
|
73
|
66
|
70
|
80
|
81
|
78
|
78
|
80
|
80
|
75
|
69
|
|
| Net Income (Common) |
50
N/A
|
56
+12%
|
73
+30%
|
66
-9%
|
70
+6%
|
80
+14%
|
81
+1%
|
78
-3%
|
78
0%
|
80
+3%
|
80
-1%
|
75
-6%
|
69
-7%
|
|
| EPS (Diluted) |
0.44
N/A
|
0.5
+14%
|
0.65
+30%
|
0.59
-9%
|
0.62
+5%
|
0.72
+16%
|
0.72
N/A
|
0.69
-4%
|
0.69
N/A
|
0.72
+4%
|
0.71
-1%
|
0.67
-6%
|
0.62
-7%
|
|